Chicago Foundation for Women Grants $15,000 to Pediatric AIDS Chicago Prevention Initiative to Make an Investment in Women and Girls
Chicago Foundation for Women’s spring 2015 primary cycle focused on freedom from violence and health access and awareness.
Pediatric AIDS Chicago Prevention Initiative (PACPI) was awarded $15,000 for their Perinatal HIV Enhanced Case Management from the General Fund at Chicago Foundation for Women. The spring 2015 primary cycle at Chicago Foundation for Women awarded $570,000 in grants to 34 Chicagoland programs. Perinatal HIV Enhanced Case Management intends to help vulnerable HIV-positive pregnant women to have healthy, HIV-negative newborns and establish a strong connection to continuing care for each mother and child.
CFW awarded 12 grants focused on access to health and health information. CFW grantees in the health portfolio are committed to supporting some of the most vulnerable women in Chicago. All grantee organizations serve or impact low-income women or women below the poverty line.
READ MORE >>
5 Reasons to Visit the New 24/7 Illinois Perinatal HIV Hotline Website
- The new Hotline website is easier to navigate and has a cleaner look. Key resources are quickly found on the home page.
- Caring for an HIV-positive woman in labor? The “hot” red button at the top of the home page lists step-by-step instructions on how to treat your patient. Call the Hotline and we’ll provide clinical consultation, referral, and follow-up assistance.
- Quickly access links to best practices and care recommendations for HIV-positive women in labor and women or infants with preliminary positive rapid HIV tests.
- You’ll find recent news and research as well as links for patients and other service providers.
- The Hotline website is THE resource for anything related to pregnancy and HIV.
SHARE the Hotline website with anyone who works in a hospital, clinic-based setting, or social service agency that serves pregnant women.
The National Institutes of Health (NIH) announced this week that the findings from their PROMISE randomized clinical trial shows that taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor and two more after giving birth.
“This is another important step in our efforts to define the best approaches toward the goal of eliminating of mother-to-child HIV transmission globally,” Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH.
The study enrolled more than 3,500 HIV-infected pregnant or post-partum women who did not meet national criteria for receiving anti-HIV treatment and more than 3,200 HIV-exposed infants of these women in India, Malawi, South Africa, Tanzania, Uganda, Zambia and Zimbabwe.
The participating women and children are being followed until two years after the last child is born to address questions about the safety and efficacy of anti-HIV drug regimens taken during the breastfeeding period. The study also is assessing maternal health after the breastfeeding period among women in good immune health who either stop or continue taking triple-drug anti-HIV regimens.
Dr. Donna Hubbard McCree of the Centers for Disease Control and Prevention talks about an encouraging decrease in new HIV infections among black women in a video posted on YouTube. Published on Jan 28, 2013.
PACPI Executive Director Anne Statton and PACPI Board Members Dr. Patricia Garcia and Dr. William Grobman co-authored the article “Perinatal HIV testing and diagnosis in Illinois after implementation of the Perinatal Rapid Testing Initiative” in the November 2012 American Journal of Obstetrics & Gynecology. Read the article (PDF), written in collaboration with Dr. Amy Wong, Yolanda Olszewski, Dr. Ann Bryant Borders, and Dr. Mardge Cohen.
The Illinois Department of Public Health revised HIV testing regulations in 2012 to reflect changes made to the Illinois state law. Read the new guidelines here (PDF).
A comprehensive report and guide outlining the medical and legal surrounding HIV and pregnancy in the US is available through the Center for HIV Law & Policy website. The Legal Supplement, available upon request, details the legal issues advocates may face when representing a woman living with HIV throughout pregnancy, and provides legal arguments and strategies to best represent women living with HIV.
To request a copy of the Legal Supplement, please contact Rene Bennett at email@example.com.
To download the HIV and Pregnancy guide (without the Supplement), go to: http://www.hivlawandpolicy.org/resources/view/474.